700 - The Pros, Cons, and Unknowns of Ozempic

<p data-pm-slice="1 1 []">Medications like Ozempic, Wegovy, and Mounjaro show lots of promise for treating obesity but scientists still don’t understand exactly how they work. There’s also a lack of data to show whether these medications are safe to take long term. <strong>Dr. Sameer Khan</strong>, a Johns Hopkins fellow in gasteroenterology, talks with <strong>Dr. Josh Sharfstein</strong> about what these medicines are and what they can do, the questions that remain, and why it’s a challenge for clinicians to prescribe them and for patients to actually obtain them. Learn more about another one of our projects, the Expert Insights newsletter: <a href= "http://publichealth.jhu.edu/subscribe">publichealth.jhu.edu/subscribe</a></p>